Literature DB >> 15197061

Clinical trial performance of community- vs university-based practices in the submacular surgery trials (SST): SST report no. 2.

Neil M Bressler1, Barbara S Hawkins, Susan B Bressler, Päivi H Miskala, Marta J Marsh.   

Abstract

OBJECTIVE: To compare the performance of community- vs university-based clinical centers in 3 multicenter randomized clinical trials of intraocular surgery.
METHODS: Each Submacular Surgery Trials clinical center was classified as a university-based center, if the contract to perform as a center was signed by a university official, or as a community-based center. The 2 groups of centers were compared on performance, assessed cumulatively by the Submacular Surgery Trials Quality Assurance and Monitoring Subcommittee. OUTCOME MEASURES: Patient accrual, completion of scheduled examinations, completion of masked vision examinations 2 years after enrollment (the designated primary study end point evaluation time), timeliness of submission of retinal photographs required by protocol to the Photograph Reading Center, completion of health- and vision-related quality-of-life interviews, and timeliness of submission of the primary outcome data to the Coordinating Center after completion of the examination.
RESULTS: Almost all centers performed at a very high (good) level, although there was a trend for some community-based centers to be at the lower end of most distributions.
CONCLUSIONS: Most community- and university-based centers performed well in these multicenter clinical trials. Monitoring performance and periodically providing feedback to clinical center investigators may encourage excellent performance in areas critical to the success of clinical trials, regardless of whether the center is community or university based.

Entities:  

Mesh:

Year:  2004        PMID: 15197061      PMCID: PMC1282459          DOI: 10.1001/archopht.122.6.857

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  14 in total

1.  Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1.

Authors:  N M Bressler; S B Bressler; B S Hawkins; M J Marsh; P Sternberg; M A Thomas
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

2.  Patients' perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularization--The Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6.

Authors:  Eric B Bass; Marsha J Marsh; Carol M Mangione; Neil M Bressler; Ashley L Childs; Li Ming Dong; Barbara S Hawkins; Harris A Jaffee; Päivi Miskala
Journal:  Arch Ophthalmol       Date:  2004-12

3.  Quality of institutional participation in multicenter trials.

Authors: 
Journal:  N Engl J Med       Date:  1982-04-01       Impact factor: 91.245

4.  Participation of community hospitals in clinical trials: analysis of five years of experience in the Eastern Cooperative Oncology Group.

Authors:  C B Begg; P P Carbone; P J Elson; M Zelen
Journal:  N Engl J Med       Date:  1982-05-06       Impact factor: 91.245

5.  Quality of institutional participation in multicenter clinical trials.

Authors:  R J Sylvester; H M Pinedo; M De Pauw; M J Staquet; M E Buyse; J Renard; G Bonadonna
Journal:  N Engl J Med       Date:  1981-10-08       Impact factor: 91.245

6.  A comparison of the quality of participation of community affiliates and that of universities in the Northern California Oncology Group.

Authors:  M M Koretz; P M Jackson; F M Torti; S K Carter
Journal:  J Clin Oncol       Date:  1983-10       Impact factor: 44.544

7.  On the detection of outlier clinics in medical and surgical trials: I. Practical considerations.

Authors:  P L Canner; Y B Huang; C L Meinert
Journal:  Control Clin Trials       Date:  1981-09

8.  Performance evaluation in multicenter clinical trials: development of a model by the AIDS Clinical Trials Group.

Authors:  L L Rosendorf; U Dafni; D A Amato; B Lunghofer; J G Bartlett; J M Leedom; D W Wara; J A Armstrong; E Godfrey; E Sukkestad
Journal:  Control Clin Trials       Date:  1993-12

9.  Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT).

Authors:  J L Keltner; C A Johnson; R W Beck; P A Cleary; J O Spurr
Journal:  Control Clin Trials       Date:  1993-04

10.  Relationship between rate of patient enrollment and quality of clinical center performance in two multicenter trials in ophthalmology.

Authors:  B S Hawkins; M J Prior; M R Fisher; D W Blackhurst
Journal:  Control Clin Trials       Date:  1990-10
View more
  5 in total

1.  Recruitment of participants to a multiple sclerosis trial: the CombiRx experience.

Authors:  Minal J Bhanushali; Tarah Gustafson; Steve Powell; Robin A Conwit; Jerry S Wolinsky; Gary R Cutter; Fred D Lublin; Stacey S Cofield
Journal:  Clin Trials       Date:  2014-04       Impact factor: 2.486

2.  Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13.

Authors:  Neil M Bressler; Susan B Bressler; Ashley L Childs; Julia A Haller; Barbara S Hawkins; Hilel Lewis; Mathew W MacCumber; Marta J Marsh; Maryann Redford; Paul Sternberg; Matthew A Thomas; George A Williams
Journal:  Ophthalmology       Date:  2004-11       Impact factor: 12.079

3.  Age-related macular degeneration: current treatments.

Authors:  Jean Pierre Hubschman; Shantan Reddy; Steven D Schwartz
Journal:  Clin Ophthalmol       Date:  2009-06-02

4.  Improving the recruitment activity of clinicians in randomised controlled trials: a systematic review.

Authors:  Ben Fletcher; Adrian Gheorghe; David Moore; Sue Wilson; Sarah Damery
Journal:  BMJ Open       Date:  2012-01-06       Impact factor: 2.692

Review 5.  Requirements and Study Designs for U.S. Regulatory Approval of Influenza Home Tests.

Authors:  Tony Yang; Larry G Kessler; Matthew J Thompson; Barry R Lutz
Journal:  J Clin Microbiol       Date:  2021-12-15       Impact factor: 11.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.